STERIS (STE) Stock Price, News & Analysis

Company Overview

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories. In addition to hardware and consumables, STERIS provides validation, advisory and technical field services such as installation, maintenance, validation testing and training to help customers meet regulatory and operational requirements.

STERIS serves a worldwide customer base that includes hospitals and health systems, ambulatory surgery centers, pharmaceutical and biotechnology manufacturers, medical device companies, and research institutions. The company operates manufacturing, distribution and service facilities across multiple regions to support customers’ clinical and production needs and to provide local service and regulatory support.

Over time STERIS has expanded its product and service scope to address a range of infection-prevention and contamination-control challenges across clinical and industrial settings. The company positions itself as a partner to organizations seeking to improve patient safety, ensure regulatory compliance and maintain uptime for critical sterilization and reprocessing operations.

Key Stats

• Today's Range: $215.32 to $219.98
• 50-Day Range: $201.95 to $226.25
• 52-Week Range: $195.14 to $269.44
• Volume: 645,464 shs
• Average Volume: 831,525 shs
• Market Capitalization: $21.25 billion
• P/E Ratio: 27.32
• Dividend Yield: 1.16%
• Price Target: $274.25
• Consensus Rating: Moderate Buy

STERIS Stock Analysis - MarketRank™

STERIS scored higher than 92% of companies evaluated by MarketBeat, and ranked 49th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.9 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

STERIS has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on no strong buy ratings, 3 buy ratings, 2 hold ratings, and no sell ratings.

Upside Potential

STERIS has a consensus price target of $274.25, representing about 26.6% upside from its current price of $216.69.

Amount of Analyst Coverage

STERIS has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 7.69%

Earnings Growth

Earnings for STERIS are expected to grow by 7.69% in the coming year, from $11.18 to $12.04 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of STERIS is 27.32, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 43.12.

Price to Earnings Ratio vs. Sector

The P/E ratio of STERIS is 27.32, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 17.94.

Price to Book Value per Share Ratio

STERIS has a P/B Ratio of 2.95. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.92% of the float of STERIS has been sold short.

Short Interest Ratio / Days to Cover

STERIS has a short interest ratio ("days to cover") of 2.72, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in STERIS has recently increased by 15.34%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

STERIS pays a meaningful dividend of 1.16%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

STERIS has been increasing its dividend for 20 years.

Dividend Coverage

The dividend payout ratio of STERIS is 31.78%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, STERIS will have a dividend payout ratio of 20.93% next year. This indicates that STERIS will be able to sustain or increase its dividend.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.50

News Sentiment

STERIS has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for STERIS this week, compared to 3 articles on an average week.

Search Interest

Only 13 people have searched for STE on MarketBeat in the last 30 days. This is a decrease of -24% compared to the previous 30 days.

MarketBeat Follows

Only 2 people have added STERIS to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, STERIS insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $734,877.00 in company stock.

Percentage Held by Insiders

1.07% of the stock of STERIS is held by insiders.

Percentage Held by Institutions

94.69% of the stock of STERIS is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 3/19 Dividend: 2/17/2026
• Ex-Dividend for 3/19 Dividend: 2/17/2026
• Dividend Payable: 3/19/2026
• Last Earnings: 5/11/2026
• Today: 5/24/2026
• Record date for 6/26 Dividend: 6/08/2026
• Ex-Dividend for 6/26 Dividend: 6/08/2026
• Dividend Payable: 6/26/2026
• Next Earnings (Estimated): 8/05/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:STE
• CIK: 1757898
• Web: www.steris.com
• Phone: (440) 354-2600
• Fax: 440-639-4457
• Employees: 17,787
• Year Founded: 1985

Price Target and Rating

• Average Price Target for STERIS: $274.25
• High Price Target: $295.00
• Low Price Target: $263.00
• Potential Upside/Downside: +26.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.60
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): $7.93
• Trailing P/E Ratio: 27.32
• Forward P/E Ratio: 19.38
• P/E Growth: N/A
• Net Income: $782.30 million
• Net Margins: 13.18%
• Pretax Margin: 17.64%
• Return on Equity: 14.15%
• Return on Assets: 9.52%

Debt

• Debt-to-Equity Ratio: 0.25
• Current Ratio: 2.09
• Quick Ratio: 1.54

Sales & Book Value

• Annual Sales: $5.94 billion
• Price / Sales: 3.58
• Cash Flow: $13.69 per share
• Price / Cash Flow: 15.83
• Book Value: $73.39 per share
• Price / Book: 2.95

Miscellaneous

• Outstanding Shares: 98,070,000
• Free Float: 97,026,000
• Market Cap: $21.25 billion
• Optionable: Optionable
• Beta: 0.95